Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by SPR Therapeutics, Inc.

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting
From SPR Therapeutics, Inc.
Via GlobeNewswire
Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPRINT® PNS Demonstrates Robust Results in Addressing Chronic Shoulder Pain
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
From SPR Therapeutics, Inc.
Via GlobeNewswire
New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
From SPR Therapeutics, Inc.
Via GlobeNewswire
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
From SPR Therapeutics, Inc.
Via GlobeNewswire
Tickers SLRC
SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain
From SPR Therapeutics, Inc.
Via GlobeNewswire
New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR Therapeutics Named a Top Workplace for Second Consecutive Year
From SPR Therapeutics, Inc.
Via GlobeNewswire
Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS
From SPR Therapeutics, Inc.
Via GlobeNewswire
SelectHealth Initiates Peripheral Nerve Stimulation (PNS) Coverage to Support Patient Need for Effective Non-opioid Pain Treatment
From SPR Therapeutics, Inc.
Via GlobeNewswire
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System
From SPR Therapeutics, Inc.
Via GlobeNewswire
SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022
From SPR Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.